Postherpetic neuralgia in the elderly
Open Access
- 1 September 2009
- journal article
- review article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 63 (9) , 1386-1391
- https://doi.org/10.1111/j.1742-1241.2009.02089.x
Abstract
Postherpetic neuralgia (PHN) is the most common complication of herpes zoster (HZ) or ‘shingles’ and affects a significant proportion of HZ patients with the disease, with the elderly being most frequently and seriously affected. Characterised by various types of pain (constant, intermittent and stimulus evoked) that persist between 3 months and many years after the resolution of the HZ rash, PHN can have a severe impact on the patient’s quality of life and functional ability. PHN remains highly resistant to current treatments. In this review, we discuss the epidemiology, clinical features and management of PHN in the elderly and the potential of vaccination against varicella zoster virus as a means to prevent HZ, and thus decrease the incidence and severity of PHN.Keywords
This publication has 61 references indexed in Scilit:
- Vaccination against Herpes Zoster and Postherpetic NeuralgiaThe Journal of Infectious Diseases, 2008
- Natural History and Treatment of Herpes ZosterThe Journal of Pain, 2008
- Herpes Zoster and Postherpetic NeuralgiaDrugs & Aging, 2008
- Post-Herpetic Neuralgia in Older AdultsDrugs & Aging, 2007
- Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic ReviewPLoS Medicine, 2005
- Aging, Immunity, and the Varicella–Zoster VirusNew England Journal of Medicine, 2005
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Treatment of postherpetic neuralgia: a review of therapeutic optionsJournal of Pain and Symptom Management, 2004
- A study of shingles and the development of postherpetic neuralgia in East LondonJournal of Medical Virology, 2003
- Aging, Natural Death, and the Compression of MorbidityNew England Journal of Medicine, 1980